Avidity Biosciences
RNAM
#1866
Rank
A$15.95 B
Marketcap
A$103.31
Share price
0.00%
Change (1 day)
108.93%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: A$15.95 Billion

As of June 2026 Avidity Biosciences has a market cap of A$15.95 Billion. This makes Avidity Biosciences the world's 1866th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026A$15.95 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$211.92 B 1,227.94%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$150.88 B 845.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$2.29 B-85.63%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$8.84 B-44.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.34 B-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.16 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.50 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$5.44 B-65.88%๐Ÿ‡บ๐Ÿ‡ธ USA